Vasculitides (Large / Medium / Small Vessel)
USMLE Step 1 trap: Confuses Takayasu arteritis and GCA by failing to distinguish their age demographics and target vessels. Takayasu arteritis affects women under 40 and primarily involves the aorta and its major branches causing arm claudication and pulse deficits, while GCA affects patients over 50 and primarily involves the temporal artery causing headache, jaw claudication, and vision loss.
Vasculitides are inflammatory diseases of blood vessels, and USMLE Step 1 loves them because they're pattern-recognition gold — each one has a specific demographic, target vessel, ANCA status, and associated findings that distinguish it from every other. Students consistently confuse GCA with Takayasu arteritis since both are granulomatous large-vessel diseases, but they belong to completely different age groups: Takayasu strikes young women under 40 with arm claudication, while GCA targets patients over 50 with jaw claudication and risk of vision loss. The classification by vessel size (large, medium, small) is your organizing framework, but the exam doesn't just ask you to categorize. It gives you a clinical vignette — a 68-year-old woman with jaw claudication and sudden vision loss, or a child with purpura and joint pain after a URI — and expects you to name the disease, predict the complication, identify the ANCA marker, or make the next management decision.
The tricky part is that several of these diseases overlap superficially. Both GCA and Takayasu are large-vessel granulomatous vasculitides, but they hit completely different age groups and vascular territories. All three ANCA-associated vasculitides (GPA, EGPA, MPA) involve small vessels and can cause pulmonary-renal syndrome, but their ANCA types and clinical signatures differ. Students who memorize lists without anchoring the features to mechanism or demographics fall apart on the application questions. The exam also frequently tests management decisions — specifically, whether you'd delay steroids in suspected GCA while waiting for a biopsy (you shouldn't).
For USMLE Step 1, build your mental model around three axes for each vasculitis: vessel size, ANCA status, and organ signature. If you can triangulate those three things, you'll nail the vignette. The high-yield traps are PAN being ANCA-negative despite being a systemic vasculitis, EGPA being distinguished by asthma and eosinophilia (not just ANCA), and the management pearl that steroids must precede biopsy in GCA.
One of the more frequently lapsed topics in Cardiovascular — most students have the cards but struggle to retain them.
Common misconceptions
What the exam tests
- Identify the defining clinical and demographic features of GCA (temporal arteritis) versus Takayasu arteritis — including age of onset, affected vessels, and classic symptoms like jaw claudication, vision loss, or arm pulse deficits.
- Distinguish PAN, Kawasaki disease, and Buerger disease as medium-vessel vasculitides by their unique associations: PAN with hepatitis B and renal involvement, Kawasaki with children and coronary artery aneurysms, Buerger with heavy smoking and distal limb ischemia.
- Differentiate the three ANCA-associated small-vessel vasculitides — GPA (c-ANCA/PR3), EGPA (p-ANCA/MPO with asthma and eosinophilia), and MPA (p-ANCA/MPO without granulomas) — based on ANCA type, granuloma presence, and organ involvement.
- Recognize IgA vasculitis (HSP) by its classic tetrad: palpable purpura on the lower extremities, arthralgia, abdominal pain, and renal involvement, typically following an upper respiratory infection in a child.
Can you avoid these mistakes?
Related topics
See how your Anki deck covers this topic.
Upload your deck for a free audit →